Skip to content

En
Sv

Governance
- Back
Governance
Career
Media
- Back
Media
Contact us

Sweden
Norway
Finland
Denmark transparancy reporting

En
Sv

About us
- Back
About us
- - Leadership
  - Testimonials
Research and Strategy
- Back
Research and Strategy
Sustainability
- Back
Sustainability
Investors
- Back
Investors
Partnering
- Back
Partnering

Search for:

Search

Loading...

Governance
- Back
Governance
Career
Media
- Back
Media
Contact us

Sweden
Norway
Finland
Denmark transparancy reporting

Search for:

Press to Search

Loading...

BioArctic
Investors
Conference presentations
Exidavnemab presentation at 2025 AD/PD™ congress

Loading...

Exidavnemab presentation at 2025 AD/PD™ congress

April 5, 2025

Documents

Exidavnemab (BAN0805) offers opportunities as a potential disease modifying therapy in several synucleinopathies ADPD 2025 April 5, 2025

Collaboration

Quick links

About us
Research and Strategy
Six reasons to invest in BioArctic
Sustainability

Socials

Financial calendar
Financial reports
Share information
Contact us

Privacy Notice
Cookies